Please assess the completion status of the following clinical trial:

Trial Title: Treatment of ppROM With Erythromycin vs. Azithromycin Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Maternal age ≥ 18 years and \<50 years~* Pregnant women between the gestational age 23 6/7 and 32 6/7 weeks~* Singleton pregnancy~* Preterm premature rupture of membranes, determined clinically~* Cervical dilation visually ≤ 5cm on sterile speculum exam.~* Planned delivery at John Sealy Hospital (JSH)~Exclusion Criteria:~* Intrauterine fetal demise (no fetal heart beat identified and documented by two physicians)~* Any contraindication to expectant management (e.g. fetal compromise, chorioamnionitis, placental abruption)~* Cervical cerclage in place~* Placenta previa or other known placental anomalies~* Contraindication to any of the antibiotics used (allergy to macrolides).~* Enrolled in another trial that may affect outcome.~* Clinical chorioamnionitis or any other active bacterial infection (e.g. pyelonephritis, pneumonia, abscess) at time of randomization: because standard antibiotic therapy for these conditions may confound trial intervention.~* No prenatal care (less than 2 prenatal visits)~* Non-resident subject who is unlikely to be followed-up after delivery~* Any fetal congenital anomaly.~* Significant liver disease defined as known cirrhosis or elevated transaminases of at least 3-fold upper limit of normal~* Significant renal disease defined as serum creatinine known to be \>2.0 mg/dl or on dialysis.~* Active congestive heart failure (EF\<45%) or pulmonary edema.~* Immunosuppressed subjects: i.e., taking systemic immunosuppressants or steroids (e.g. transplant subjects; not including steroids for lung maturity), HIV with CD4\<200, or other.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Azithromycin (Type: EXPERIMENTAL): Ampicillin 2 gm IV every 6 hours followed by amoxicillin 500 mg PO every 8 hours with Azithromycin 1 gm PO once at randomization.
- Erythromycin (Type: ACTIVE_COMPARATOR): Ampicillin 2 gm IV every 6 hours followed by amoxicillin 250 mg PO every 8 hours for 5 days with erythromycin 250 mg IV every 6 hours for 48 hours followed by 500 mg PO every 8 hours for 5 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).